SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-171020
Filing Date
2022-06-09
Accepted
2022-06-09 16:06:00
Documents
12
Period of Report
2022-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d326796d8k.htm   iXBRL 8-K 32699
  Complete submission text file 0001193125-22-171020.txt   154139

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mack-20220606.xsd EX-101.SCH 2881
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20220606_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20220606_pre.xml EX-101.PRE 11278
6 EXTRACTED XBRL INSTANCE DOCUMENT d326796d8k_htm.xml XML 3391
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 221005999
SIC: 2834 Pharmaceutical Preparations